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PET scanIntroduction
Early-stage cervical cancer can be potentially cured with radical
hysterectomy or chemoradiation therapy. Unfortunately, based on
data from retrospective studies, up to 17% of patients with this dis-
ease will recur (Larson et al., 1988; Esajas et al., 2001; Soisson
et al., 1990; Ansink et al., 1996). Disease recurrence often presents
within 2 years after primary treatment, and recurrences after radical
hysterectomy commonly occur locally as central pelvic recurrences
due to the extent of spread into contiguous tissues (Di Saia et al.,
2012). The surgical management of a central recurrence in a previously
irradiated ﬁeld typically requires a pelvic exenteration. Exenterative
procedures, however, are associated with signiﬁcant operative and
postoperative complications as well as long-term morbidity predomi-
nantly related to urinary tract diversion (Di Saia et al., 2012). In the
less common case of an isolated recurrence, limited surgical excision
with clearmarginsmay offer curative therapywhile avoiding the signif-
icantmorbidity associatedwith exenteration.We report a case of isolat-
ed recurrent cervical cancer in the sigmoid colon arising 2 years after
primary surgical therapy and treated by partial sigmoid resection with
a primary anastomosis followed by chemoradiation therapy.
Case report
The patient is a 37-year-old woman who was initially seen at our
institution in 2010 after colposcopic biopsies and endocervical curettage⁎ Corresponding author at: Gynecology Service, Department of Surgery, Memorial Sloan-
Kettering Cancer Center, 1275 York Avenue, New York, NY 10065. Fax: +1 212 717 3214.
E-mail address: barakatr@mskcc.org (R.R. Barakat).
2211-338X © 2013 The Authors. Published by Elsevier Inc.
http://dx.doi.org/10.1016/j.gynor.2013.07.005
Open access under CC BY-NC-ND license.at an outside hospital demonstrated poorly differentiated adenocar-
cinoma. On exam, she was noted to have an approximately 2 cm
gross circumferential, exophytic cervical lesion without parametrial
involvement. Fused positron emission tomography and computed
tomography (PET/CT) scanning demonstrated no evidence of meta-
static disease. She was counseled on management options for stage
IBI cervical cancer, including primary chemoradiation versus primary
radical surgery, and opted for upfront surgical management. In October
2010, she underwent robotic-assisted laparoscopic radical hysterecto-
my, sentinel lymph node mapping, bilateral pelvic lymphadenectomy
and bilateral ovarian transposition. Sentinel node mapping and subse-
quent bilateral pelvic lymphadenectomy were performed per our insti-
tutional protocol. Final surgical pathology showed poorly differentiated
endocervical adenosquamous carcinoma growing as an exophytic
polypoid mass measuring 2.2 cm, invading the cervical stroma to a
depth of 1 mmout of 12 mm; therewas no vaginal or parametrial exten-
sion, and surgical margins were negative. There was no lymphovascular
invasion, and all nine submitted lymph nodes were negative. The patient
did well postoperatively and did not receive adjuvant treatment.
She was without evidence of disease on routine surveillance exams
until she experienced hematochezia in July 2012, which spontaneously
resolved. She had recurrent bloody stools in October 2012, prompting a
colonoscopy at anoutside facility. This study revealed apolypoid, partially
obstructing circumferential large mass in the sigmoid colon, approxi-
mately 15 cm from the anal verge, concerning for a new primary colon
carcinoma. Her ﬁnal pathology, however, demonstrated carcinoma with
squamous differentiation involving fragments of ﬁbrous tissue and posi-
tive for p16, consistent with a likely recurrence of her cervical cancer. As
illustrated in the graphical abstract, PET/CT scanning performed to assess
the extent of disease spread showed a hypermetabolic isolated sigmoid
colon lesion (SUV 26) without evidence of distant metastatic spread.
Given this isolated focus of recurrence, the decision was made to
proceed with surgical resection of the mass following colonoscopic
tattooing of the lesion with India ink to guide a laparoscopic approach
(Fig. 1). In December 2012, she underwent robotic-assisted laparoscopic
rectosigmoid resection with end-to-end colorectal anastomosis approxi-
mately 12 cm from the anal verge. A small Pfannenstiel incision was
made in order to remove the excised specimen. Intraoperatively, there
was no gross evidence of other sites ofmetastatic spread and no evidence
of disease at the vaginal cuff; the peritoneal surfaces were noted to be
smooth, and an upper abdominal survey was unremarkable. There were
no intraoperative or postoperative complications, and the patient recov-
ered uneventfully from this procedure. Final surgical pathology showed
metastatic carcinoma with squamous differentiation, with the tumor
measuring 4.5 cm and involving the full thickness of the colon wall
from mucosa to serosa; surgical resection margins were negative.
Fig. 1. Preoperative colonoscopy revealed a malignant partially obstructing tumor in the sigmoid colon. The lesion was tattooed with 5 mL of India ink.
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ning conference, and the decision was made to proceed with postop-
erative chemoradiation as the standard of care for pelvic failure after
previous surgical therapy alone. She received chemoradiation with
weekly radiosensitizing cisplatin for a total dose of 4500 cGy given
in 25 fractions, which was completed March 2013. Surveillance CT
imaging in May 2013 showed no evidence of disease.
Discussion
After primary surgery for cervical cancer, pelvic recurrence is
generally managed with chemoradiation due to the presentation of
a central pelvic vaginal cuff recurrent lesion, as seen in 35–40% of recur-
rences after radical hysterectomy (Peiretti et al., 2012). Surgical man-
agement of regionally recurrent cervical cancer in the setting of prior
hysterectomy typically involves radical pelvic surgery in order to
achieve surgical resection with curative intent. However, the utility of
limited surgical resection for isolated disease recurrence should be con-
sidered in cases in which cure might be achieved without the need for
radical exenterative surgery. We present an unusual case of pelvic
recurrence isolated to a segment of the sigmoid colon treated by robot-
ically assisted laparoscopic rectosigmoid resection,with achievement of
negative surgical margins. There was a sufﬁcient degree of redundancy
noted in the descending colon and rectosigmoid to allow for a tension-
free primary anastomosis in order to avoid ostomy creation.
Surgical resection in cervical cancer recurrence has been reported
for other sites of isolated metastases, for example, with pulmonary
lesions (Lim et al., 2010) and isolated splenic metastasis (Di Donato
et al., 2010). In the setting of gastrointestinal tract recurrences, how-
ever, intraperitoneal seeding or tethering of bowel loops to mesen-
teric tumor implants often preclude focal resection due to diffuse
spread and poor prognosis. While the rectum is frequently involved
with centrally recurrent cervical cancer due to contiguous extension
(Fulcher et al., 1999), isolated recurrent cervical cancer occurring
within the colon or rectal lumen is rare. One case report describes a
patient with early-stage cervical cancer treated by radical hysterec-
tomy, who then recurred 15 years later with an initial complaint of
rectal bleeding (Sweetser and Ahlquist, 2010). Colonoscopy demon-
strated a mass lesion within the rectum mimicking rectal cancer. In
this case, however, imaging demonstrated a contiguous pelvic mass be-
tween the sacrum and rectum. She received chemoradiation with near
complete regression of the pelvic mass followed by surgical resection
of residual disease with intraoperative radiation therapy. No follow-
up information is provided.
We acknowledge that only nine pelvic lymph nodes were removed
at the time of the patient’s primary surgery, which may suggest thather recurrence risk was increased by an incomplete nodal assessment.
However, given that her PET/CT imaging prior to her rectosigmoid
resection demonstrated no abnormal uptake in the abdominopelvic
nodes, we believe the initial nodal assessment was adequate. As
such and per the surgeon’s discretion, we felt that a minimally inva-
sive procedure without additional lymph node sampling at the time
of her recurrence was a favorable option in order to minimize her
intraoperative and postoperative morbidity. Additionally, the pa-
tient underwent sentinel node mapping at the time of her initial sur-
gery. Although sentinel node mapping in the setting of cervical
cancer is still considered investigational, it has gained increasing
support in the literature, demonstrating a potential role for sparing
complete nodal dissection while still accurately identifying nodal
metastases (Cibula et al., 2012; Cormier et al., 2011; Selman et al.,
2008).
Concurrent cisplatin-based chemotherapy and radiation were also
administered to our patient postoperatively as the treatment of choice
for recurrent centrally located cervical cancer following primary surgery
alone (Leitao and Chi, 2002; Gadducci et al., 2010). Because isolated
cervical cancer recurrence to the rectosigmoid colon is rare, prospec-
tive data regarding the addition of chemoradiation in this particular
setting are lacking. However, in locally recurrent disease, radiation
offers long-term pelvic control and prolonged survival (Cervical
Cancer, 1996). In this case report, there was no gross residual disease
following anterior rectosigmoid resection, but chemoradiation was
clinically indicated given the high risk of residual microscopic tumor.
Similarly, outcome data to guide the decision to treat by surgery
alone versus combined surgerywith chemoradiation for conﬁned recur-
rent disease after surgery alone are sparse. One recent retrospective
study examining outcomes of patients undergoing salvage therapy for
recurrent cervical cancer following radical hysterectomy found that pa-
tients undergoing surgery plus chemotherapy or concurrent chemora-
diation had worse survival rates after recurrence compared with those
undergoing surgery alone (Cervical Cancer, 1996). However, the au-
thors speculated that receiving chemotherapy or chemoradiation was
a surrogate formore extensive disease, in which providers believed sur-
gery alone was not sufﬁcient treatment. Therefore, it remains that the
approach to recurrent cervical cancer should be individualized based
on the presentation of the recurrence and the patient’s performance sta-
tus. Innovative strategies such as the approach presented in this case
should be considered when possible to minimize morbidity and poten-
tially improve survival.Conﬂict of interest statement
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